Clinical Trials Logo

Filter by:
  • Completed  
  • Page [1] ·  Next »
NCT ID: NCT06207227 Completed - Vaginal Atrophy Clinical Trials

Clinical Performance and Safety of the VITA AV Clinical System

Start date: April 13, 2023
Phase: N/A
Study type: Interventional

The primary objective of this clinical investigation is to demonstrate that treatment with the VITA AV clinical system is feasible and to evaluate clinical performance and safety when used to improve the symptoms and signs of vaginal atrophy (VA) due to menopause.

NCT ID: NCT06134115 Completed - Clinical trials for Primary Knee Osteoarthritis Grade 3 - 4

LIKEST Study: Lipocet® in Adults With Primary Knee Osteoarthritis Grade 3-4

Start date: August 19, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and efficacy of Lipocet® (food supplement) in patients with primary knee osteoarthritis grade 3 - 4

NCT ID: NCT06030271 Completed - Clinical trials for Chronic Total Occlusion (CTO)

A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter

Start date: October 13, 2022
Phase: N/A
Study type: Interventional

The trial is a pivotal clinical investigation, which is a prospective, non-randomized pivotal clinical investigation to demonstrate the safety and performance of the TrueCross Single-use Microcatheter.

NCT ID: NCT05793619 Completed - Senile Lentigo Clinical Trials

Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Start date: April 4, 2023
Phase: N/A
Study type: Interventional

CS5_8 study aim to evaluate the tolerance and to adjust the mode of administration of 2 different conditions of cryotherapy treatments applied on the brown spots of the face with 1 prototype (816-v1). Each treatment corresponds to a specific frequency of cryogenic spray application. The study will evaluate the following prototype : • Prototypes from (816-v1 301) to (816-v1 355)

NCT ID: NCT05600049 Completed - Lentigo Solar Clinical Trials

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Start date: October 21, 2022
Phase: N/A
Study type: Interventional

CS5_1 study aim to evaluate the tolerance and to adjust the mode of administration of 4 different conditions of cryotherapy treatments applied on the brown spots of the face and hand with 3 prototypes. Each treatment corresponds to a combination of a specific sequence of a cryogenic spray and of a frequency of application. The study will evaluate 3 prototypes : - Prototype 1 : from (815-v1 001) to (815-v1 100) - Prototype 2 : from (815-v1 101) to (815-v1 150) - Prototype 3 : from (815-v1 151) to (815-v1 200)

NCT ID: NCT05540496 Completed - Eczema Eyelid Clinical Trials

Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema

Start date: January 11, 2021
Phase:
Study type: Observational

The eyelids are particularly susceptible to eczema. Eyelid eczemas also called palpebral eczema, are a common condition that causes the skin on or around the eyelid to become dry, itchy, and irritated. The study aims at evaluating the ocular and peri-ocular tolerance and the efficacy of the investigational product under normal conditions of use in participants with a palpebral eczema ground. This open-labeled, multicentric study was conducted under dermatological and ophthalmological control in Caucasian subjects over 18 years of age, of all skin types and having a sensitive skin, especially on eye contour. The investigational product was to be applied twice daily on eyes contour for 4 weeks.

NCT ID: NCT05501652 Completed - Heart Failure Clinical Trials

ALLEVIATE-HF-HD Study

Start date: June 30, 2022
Phase: Phase 1
Study type: Interventional

Patients with heart failure and reduced left ventricular ejection fraction (HFrEF, EF 25-39%), or mid-range left ventricular ejection fraction (HFmrEF, EF 40-49%), or preserved left ventricular ejection fraction (HFpEF, EF ≥ 50%), with mild to moderate functional limitation will be evaluated for treatment via creation of a no-implant interatrial shunt using clinical, echocardiographic, and invasive hemodynamic data.

NCT ID: NCT05438589 Completed - Clinical trials for COVID-19 Respiratory Infection

Novel Rapid POC Diagnostics for COVID-19

Start date: April 25, 2022
Phase:
Study type: Observational

This is a prospective, multicentre study in which the diagnostic accuracy of multiple Covid-19 Antigen rapid diagnostic tests will be assessed for COVID-19 case detection using prospectively collected nasal swabs and saliva samples from participants suspected to have Covid-19 infection (with or without symptoms). The study will last approximately 9 months.

NCT ID: NCT05426759 Completed - Atrial Fibrillation Clinical Trials

Atrial Deganglionation as a Therapy for Cardiac Surgery Patients With Atrial Fibrillation

Neural-AF-2
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

A prospective single-arm study of ganglionated plexi ablation in cardiothoracic surgery patients with a history of atrial fibrillation.

NCT ID: NCT05391022 Completed - Solid Tumor Clinical Trials

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Start date: July 20, 2021
Phase: Phase 1
Study type: Interventional

Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies